QR код

Validation of the 2022 European LeukemiaNet risk stratification for acute myeloid leukemia

Abstract This study aimed to validate the 2022 European LeukemiaNet (ELN) risk stratification for acute myeloid leukemia (AML). A total of 624 newly diagnosed AML patients from 1998 to 2014 were included in the analysis. Genetic profiling was conducted using targeted deep sequencing of 45 genes base...

Повний опис

Збережено в:
Автори: Ga-Young Song, Hyeon-Jong Kim, TaeHyung Kim, Seo-Yeon Ahn, Sung-Hoon Jung, Mihee Kim, Deok-Hwan Yang, Je-Jung Lee, Mi Yeon Kim, June-Won Cheong, Chul Won Jung, Jun Ho Jang, Hee- Je Kim, Joon Ho Moon, Sang Kyun Sohn, Jong-Ho Won, Seong Kyu Park, Sung-Hyun Kim, Chang Kyun Choi, Hyeoung-Joon Kim, Jae-Sook Ahn, Dennis Dong Hwan Kim
Формат: Artigo
Мова:Inglês
Опубліковано: Nature Portfolio 2024-04-01
Серія:Scientific Reports
Предмети:
Acute myeloid leukemia
Hematopoietic stem cell transplantation
Prognosis
Онлайн доступ:https://doi.org/10.1038/s41598-024-57295-5
Теги: Додати тег
Немає тегів, Будьте першим, хто поставить тег для цього запису!

Схожі ресурси